194 related articles for article (PubMed ID: 7724981)
21. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; Calabrò F; Campaldini B; Colaluca P; Molino A; Cetto GL
Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
[TBL] [Abstract][Full Text] [Related]
22. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
23. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Yamaguchi M; Fukuyama Y; Ichinose Y
Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
Nguyen NP; Leonardo JM; Karlsson U; Vos P; Bullock L; Thomas P; Lepera P; Ludin A; Chu C; Salehpour M; Jendrasiak G; Sallah S
Anticancer Res; 2002; 22(6B):3429-35. PubMed ID: 12552935
[TBL] [Abstract][Full Text] [Related]
25. Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.
Brahmer JR; Ettinger DS
Respirology; 2007 May; 12(3):320-5. PubMed ID: 17539833
[TBL] [Abstract][Full Text] [Related]
26. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
Langer CJ; Curran WJ; Keller SM; Catalano RB; Litwin S; Blankstein KB; Haas N; Campli SN; Comis RL
Cancer J Sci Am; 1996; 2(2):99-105. PubMed ID: 9166507
[TBL] [Abstract][Full Text] [Related]
27. [Surgical therapy of locally advanced non-small cell lung carcinoma].
Martelli M; Cardillo G; Lopergolo M; Facciolo F
Chir Ital; 1995; 47(3):30-3. PubMed ID: 8964096
[TBL] [Abstract][Full Text] [Related]
28. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
[TBL] [Abstract][Full Text] [Related]
29. Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging.
Kirn DH; Lynch TJ; Mentzer SJ; Lee TH; Strauss GM; Elias AD; Skarin AT; Sugarbaker DJ
J Thorac Cardiovasc Surg; 1993 Oct; 106(4):696-702. PubMed ID: 8412265
[TBL] [Abstract][Full Text] [Related]
30. [The boundaries of curation].
Debus J; Eberhardt W; Hoffmann H; Passlick B; Rübe C; Thomas M
Onkologie; 2010; 33 Suppl 5():12-20. PubMed ID: 20523102
[TBL] [Abstract][Full Text] [Related]
31. Induction therapy before surgery for non-small cell lung cancer.
Ferraldeschi R; D'Auria G; Ceratti Ade P; Assalone P; Mentuccia L; Ciprotti M; Evangelista ML; Mazzoli M; Di Fonzo C; Cortesi E
Rays; 2004; 29(4):445-52. PubMed ID: 15852734
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
[TBL] [Abstract][Full Text] [Related]
33. [Adjuvant therapy in resectable non-small cell lung cancer].
Hashimoto K; Sagawa M; Sato M; Nagamoto N; Usuda K; Ohta S; Kanma K; Imai T; Saito Y; Suda H
Gan No Rinsho; 1986 Oct; 32(13):1752-6. PubMed ID: 2432289
[TBL] [Abstract][Full Text] [Related]
34. [Stage III non-small cell lung cancers: prospects of concomitant radiochemotherapy].
Reboul F; Brewer Y; Vincent P; Taulelle M
Bull Cancer Radiother; 1995; 82(1):28-34. PubMed ID: 7702936
[TBL] [Abstract][Full Text] [Related]
35. [Neoadjuvant chemotherapy in non small cell lung cancer].
Besse B; Vignot S; Le Chevalier T
Bull Cancer; 2006 Nov; 93(11):1087-92. PubMed ID: 17145577
[TBL] [Abstract][Full Text] [Related]
36. Critical analysis of neoadjuvant therapy for Stage IIIa non-small cell lung cancer [corrected].
Murren JR; Buzaid AC; Hait WN
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):889-94. PubMed ID: 1848970
[TBL] [Abstract][Full Text] [Related]
37. [Chemotherapy in non-small cell lung cancer].
Shimokata K
Nihon Geka Gakkai Zasshi; 1997 Jan; 98(1):41-5. PubMed ID: 9046517
[TBL] [Abstract][Full Text] [Related]
38. Restaging after neo-adjuvant chemoradiotherapy for N2 non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Thorac Surg Clin; 2008 Nov; 18(4):417-21, vii. PubMed ID: 19086610
[TBL] [Abstract][Full Text] [Related]
39. [Benefits of chemotherapy of inoperable non-small cell bronchial cancers].
Trédaniel J; Lepage E; Marty M; Hirsch A
Rev Mal Respir; 1990; 7(6):493-5. PubMed ID: 2176731
[No Abstract] [Full Text] [Related]
40. Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer.
Pujol JL; Le Chevalier T; Ray P; Gautier V; Rouanet P; Arriagada R; Grunenwald D; Michel FB
Lung Cancer; 1995 Apr; 12 Suppl 1():S107-18. PubMed ID: 7551918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
